lolnc_num,long_common_name                                                                                   ,component      ,system      ,property, score
33870-7  ,Billrubin total [Presence] in Unspecfied specimen                                                  ,Bilirubin      ,XXX         ,PrThr,0
29265-6  ,Calcium [Moles/volume] corrected for albumin in Serum or Plasma                                    ,Caicium        ,Ser/Plas    ,SCnc,3
14423-8  ,Bilirubin total [Mass/volume] in Synovial fluid                                                    ,Bilirubin      ,Synv fld    ,Mcnc,0
23658-8  ,Other Antibiotic [Susceptibility]                                                                  ,Antibiotic XX) ,isolate     ,Susc,0
19000-9  ,Vancomycin [Susceptibility]                                                                        ,Vancomycin     ,isolate     ,Susc,0
14749-6  ,Glucose [Moles/volume] in Serum or Plasma                                                          ,Glucose        ,Ser/Plas    ,SCnc,3
1920-8   ,Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma                          ,Aspartate am   ,Ser/Plas    ,CCnc,2
18878-9  ,Cefazolln [Susceptibility]                                                                         ,Cefazolin      ,isolate     ,Susc,0
20442-0  ,Hepatitis B virus DNA [ll/volume] (viral load) in Serum by Probe with signal amplification         ,Hepatitis 8 vii,Ser         ,Ncnc,0
1751-7   ,Albumin [Mass/volume] in Serum or Plasma                                                           ,Albumin        ,Ser/Plas    ,MCnc,2
13317-3  ,Methlcillin resistant Staphylococcus aureus [Presence] in Unspecified specimen by Organism specific,Staphylococci  ,XXX         ,ACnc,0
15076-3  ,Glucose [Moles/volume] in Urine                                                                    ,Glucose        ,Urine       ,SCnc,0
35184-1  ,Fasting glucose [Mass or Moles/volume] in Serum or Plasma                                          ,Glucose post   ,Ser/Plas    ,hASCnc,4
2085-9   ,Cholesterol in l-iDL [Mass/volume] in Serum or Plasma                                              ,Cholesterol.in ,Ser/Plas    ,MCnc,2
26464-8  ,Leukocytes [ll/volume] in Blood                                                                    ,Leukocytes     ,Bid         ,NCnc,0
925-8    ,Blood product disposition [Type]                                                                   ,Blood produc   ,^BPU        ,Type,2
1994-3   ,Calcium.ionized [Moles/volume] in Blood                                                            ,Calcium ionizi ,Bid         ,SCnc,1
1798-8   ,Amylase [Enzymatic activity/volume] in Serum or Plasma                                             ,Amylase        ,Ser/Plas    ,Ccnc,0
1959-6   ,Bicarbonate [Moles/volume] in Blood                                                                ,Bicarbonate    ,Bid         ,SCnc,2
1975-2   ,Bilirubin total [Mass/volume] in Serum or Plasma                                                   ,Bilirubin      ,Ser/Plas    ,MCnc,4
18928-2  ,Gentamicin [Susceptibility]                                                                        ,Gentamicin     ,isolate     ,Susc,0
14578-9  ,A80 group [Type] in Blood from Blood product unit                                                  ,A80 group      ,Bld^BPU     ,Type,2
934-0    ,Blood product unit ID [ii]                                                                         ,Blood product  ,Dose        ,Nuni,4
4671-4   ,Protein C [Mass/volume] in Plasma                                                                  ,Protein C      ,Plas        ,MCnc,3
2069-3   ,Chloride [Moles/volume] in Blood                                                                   ,Chloride       ,Bid         ,SCnc,3
2111-3   ,Choriogonadotropin beta subunit [Moles/volume] in Serum or Plasma                                  ,Choriogonadc   ,Ser/Plas    ,SCnc,0
17861-6  ,Calcium [Mass/volume] in Serum or Plasma                                                           ,Calcium        ,Ser/Plas    ,MCnc,3
2075-0   ,Chloride [Moles/volume] in Serum or Plasma                                                         ,Chloride       ,Ser/Plas    ,SCnc,1
933-2    ,Blood product type                                                                                 ,Blood product  ,^BPU        ,Type,3
2132-9   ,Cobalamin (Vitamin B12) [Mass/volume] in Serum                                                     ,Cobalamins     ,Ser         ,MCnc,0
19080-1  ,Choriogonadotropin [Units/volume] in Serum or Plasma                                               ,Choriogonadc   ,Ser/Plas    ,ACnc,4
26478-8  ,Lymphocytes/100 leukocytes in Blood                                                                ,Lymphocytes    ,Bld         ,NFr,4
14747-0  ,Glucose [Moles/volume] in Pleural ﬂuid                                                             ,Glucose        ,Plr fid     ,SCnc,0
20565-8  ,Carbon dioxide total [Moles/volume] in Blood                                                       ,Carbon dioxid  ,Bld         ,SCnc,2
2028-9   ,Carbon dioxide total [Moles/volume] in Serum or Plasma                                             ,Carbon dioxid  ,Ser/Plas    ,SCnc,3
18955-S  ,Nitrofurantoin [Susceptibility]                                                                    ,Nitrofurantoii ,Isolate     ,Susc,0
2093-3   ,Cholesterol [Mass/volume] in Serum or Plasma                                                       ,Cholesterol    ,Ser/Plas    ,hACnc,4
18998-5  ,Trimethoprim+Sulfamethoxazole [Susceptibility]                                                     ,Trimethoprim   ,Isolate     ,Susc,0
890-4    ,Blood group antibody screen [Presence] in Serum or Plasma                                          ,Blood group a  ,Ser/Plas    ,ACnc,6
14764-5  ,Glucose [Moles/volume] in Serum or Plasma --3 hours post 100 g glucose PO                          ,Glucose3H p    ,Ser/Plas    ,SCnc,1
2143-6   ,Cortisol [Mass/volume] in Serum or Plasma                                                          ,Cortisol       ,Ser/Plas    ,MCnc,4
2039-6   ,Carcinoembryonic Ag [Mass/volume] in Serum or Plasma                                               ,Carcinoembry   ,Ser/Plas    ,MCnc,4
1971-1   ,Bilirubin indirect [Mass/volume] in Serum or Plasma                                                ,Bilirubin.non-_,Ser/Plas    ,MCnc,3
18906-8  ,Ciproﬂoxacin [Susceptibility]                                                                      ,Ciprofloxacin  ,Isolate     ,Susc,0
6768-6   ,Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma                                ,Alkaline phosl ,Ser/Plas    ,CCnc,1
1988-5   ,C reactive protein [Mass/volume] in Serum or Plasma                                                ,C reactive pro ,Ser/Plas    ,MCnc,0
74774-1  ,Glucose [Mass/volume] in Serum Plasma or Blood                                                     ,Glucose        ,Ser/Plas/Bid,MCnc,5
1995-0   ,Calcium ionized [Moles/volume] in Serum or Plasma                                                  ,Calcium ionizc ,Ser/Plas    ,SCnc,1
1759-0   ,Albumin/Globulin [Mass ratio] in Serum or Plasma                                                   ,Albumin/Glob   ,Ser/Plas    ,Mcno,2
20629-2  ,Levoﬂoxacin [Susceptibility]                                                                       ,Levoﬂoxacin    ,Isolate     ,Susc,0
1968-7   ,Bilirubin direct [Mass/volume] in Serum or Plasma                                                  ,Bilirubin gluct,Ser/Plas    ,MCnc,1
35192-4  ,Bilirubin indirect [Mass or Moles/volume] in Serum or Plasma                                       ,Bilirubin non  ,Ser/Plas    ,hnSCnc,3
883-9    ,ABO group [Type] in Blood                                                                          ,ABO group      ,Bld         ,Type,4
1003-3   ,indirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma               ,Indirect antigl,Ser/Plas    ,ACnc,4
54439-5  ,Calcium bilirubinate/Total in Stone                                                                ,Calcium biliru ,Calculus    ,hAFr,0
3082-S   ,Tyrosine aminotransferase [Mass/volume] in Plasma                                                  ,Tyrosine amir  ,Plas        ,MCnc,3
30522-7  ,C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method                     ,C reactive pro ,Ser/Plas    ,hACnc,2
10331-7  ,Rh [Type] in Blood                                                                                 ,Rh             ,Bid         ,Type,4
26474-7  ,Lymphocytes [ll/volume] in Blood                                                                   ,Lymphocytes    ,Bid         ,NCnc,2
8310-5   ,Body temperature                                                                                   ,Body temper    ,Patient     ,Temp,0
31100-1  ,Hematocrit [Volume Fraction] of Blood by Impedance                                                 ,Hematocrit     ,Bld         ,VFr,1
882-1    ,A80 & Rh group [Type] in Blood                                                                     ,ABO+Rh groug   ,Bld         ,Type,3
26484-6  ,Monocytes [ll/volume] in Blood                                                                     ,Monocytes      ,Bld         ,NCnc,2
1250-0   ,Major crossmatch [interpretation]                                                                  ,Major crossm   ,Ser/Plas    ,hnp,0
18864-9  ,Ampicillin [Susceptibility]                                                                        ,Ampicillin     ,Isolate     ,Susc,0
1742-6   ,Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma                            ,Alanine aminc  ,Ser/Plas    ,CCnc,4
18865-6  ,Ampicilin+Sulbactam [Susceptibility]                                                               ,AmpiciIlin+Sui ,Isolate     ,Susc,0
